Efficacy of Bisoprolol on all-cause mortality and major cardiovascular events in haemodialysis patients

In recent years studies have evaluated efficacy in β-blockers in this population of patients receiving haemodialysis to assess the mortality and cardiovascular (CV) outcomes. ^1-3

References:

1: Weir MA et al. Journal of the American Society of Nephrology, 2015  Arp 1; 26(4): 987-96.

2: Wu PH et al. Nephrology Dialysis Transplantation. 2020 Nov;35(11): 1959-65.

3: Wu PH et al. Clinical Kidney Journal. 2021 Mar; 14(3): 983-90.